Day: August 29, 2021

OverActive Media’s League of Legends Franchise Heads into Worlds as Top European Team after Winning Back-to-Back Championships TORONTO and MADRID, Spain, Aug. 29, 2021 (GLOBE NEWSWIRE) — MAD Lions, OverActive Media’s (TSXV:OAM) professional League of Legends franchise, celebrates a first-place finish at the League of Legends European Championship (LEC) Finals this past weekend. Crowned champions earlier this season at the Spring Playoffs, MAD Lions’ Summer performance reinforces their position as the best team in Europe. They are the second-ever LEC team to win back-to-back championships since the League was franchised in 2019. MAD Lions have not lost a domestic best-of-five series in 2021. The route to the Grand Final saw MAD Lions defeat Rogue 3-0 in the winner’s bracket final on August 21. Sunday’s match...

PURCHASE, NY, Aug. 29, 2021 (GLOBE NEWSWIRE) — Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, is providing free, 24/7 general medical telehealth visits to residents, first responders and others directly impacted by Hurricane Ida and the devastating winds and flooding that have affected the area as a result. Individuals from the hardest hit areas in Louisiana and Mississippi who are now being displaced can seek treatment from a licensed health care professional for any non-emergency illness by calling Teladoc directly at 855-225-5032. “As communities seek to navigate the impact of this hurricane along with an active pandemic, we want to make sure that those faced with devastation and displacement from Ida are keeping their health front and center and know how to get care,” said Dr. Bimal Shah, chief...

Attached is a major shareholder announcement from Eimskipafélag Íslands hf. on behalf of Gildi pension fund.AttachmentFlöggun í Eimskip, Gildi-lífeyrissjóður (26.8.2021)

SHANGHAI, China, Aug. 29, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the United States Food and Drug Administration (the “FDA”), alongside the Office of the Assistant Secretary for Preparedness and Response, has resumed the shipment and distribution of etesevimab and bamlanivimab administered together (the “Therapy”), according to the company’s global partner Eli Lilly and Company (NYSE: LLY). Direct ordering will be available to authorized states in the U.S. effective immediately. The decision to resume distribution aligns with the FDA’s issuance of an updated fact sheet (the “Fact Sheet”) and a revised letter of authorization for etesevimab and...